Enzyme is projected to decline to $0.6862 by 2027, a -45% move from its current price of $1.25. MLN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.20 | $1.25 | $1.30 | -0.10% |
| Jul 13 | $1.17 | $1.25 | $1.33 | -0.19% |
| Jul 14 | $1.16 | $1.25 | $1.34 | -0.29% |
| Jul 15 | $1.14 | $1.25 | $1.36 | -0.39% |
| Jul 16 | $1.13 | $1.24 | $1.37 | -0.48% |
| Jul 17 | $1.12 | $1.24 | $1.38 | -0.58% |
| Jul 18 | $1.11 | $1.24 | $1.39 | -0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.11 | $1.24 | $1.39 | -0.67% |
| Week 2 | $1.05 | $1.23 | $1.45 | -1.34% |
| Week 3 | $1.00 | $1.22 | $1.50 | -2.01% |
| Week 4 | $0.9655 | $1.22 | $1.53 | -2.67% |
| Week 5 | $0.9331 | $1.21 | $1.57 | -3.32% |
| Week 6 | $0.9043 | $1.20 | $1.59 | -3.97% |
| Week 7 | $0.878 | $1.19 | $1.62 | -4.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MLN is the official token of Enzyme. Enzyme is the global infrastructure for tokenized finance, founded in 2017. It provides a comprehensive suite of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.
MLN sits within the Decentralized Finance (DeFi) and Asset Manager categories, with connections to the Polygon Ecosystem, Arbitrum Ecosystem, Ethereum Ecosystem, Real World Assets (RWA), and DeFiance Capital Portfolio.
Enzyme operates as a platform for tokenized finance, leveraging its Vault-As-A-Service and Financial Instruments offerings to support on-chain asset management and strategy development across multiple ecosystems and asset types.
The token and its ecosystem are positioned within DeFi and asset management spaces, reflecting its role in providing infrastructure and vehicles for on-chain asset strategies across Polygon, Arbitrum, and Ethereum ecosystems, as well as Real World Assets.
Enzyme launched on March 15, 2017.
MLN is currently priced at $1.25. It has a market cap of $4.1M and is ranked 1678. The forecast landscape yields a broad set of outcomes through 2050, with the 2026 average at $1.25 and the 2050 average at $4.98; the 2050 max reaches $11.28.
The year-by-year outlook includes both bullish and bearish years, for example 2027 with min $0.5148, avg $0.6862, max $0.9839 and ROI -45.1%, and 2033 with min $1.63, avg $2.71, max $4.80 and ROI 116.5%.
A major floor 32.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 44.5% above — a clean break opens room to run.
A major ceiling 175.4% above — clearing it would confirm fresh momentum.
Key MLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.25 | Sell | $1.26 | Sell |
| MA 10 | $1.29 | Sell | $1.30 | Sell |
| MA 20 | $1.38 | Sell | $1.39 | Sell |
| MA 50 | $1.75 | Sell | $1.77 | Sell |
| MA 100 | $2.45 | Sell | $2.34 | Sell |
| MA 200 | $3.31 | Sell | $3.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.39 | Neutral |
| Stoch RSI (14) | 63.97 | Neutral |
| CCI (20) | -77.79 | Neutral |
| Williams %R (14) | -82.31 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -9.91 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 17.69 | Buy |
| TRIX (15) | -1.39 | Sell |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 31.45 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 1.23 | Buy |
| ADX (14) | 32.88 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day trading range is $0.9839 to $1.59. The 14-day RSI is 30, and sentiment is NEUTRAL. The 50-day simple moving average is $1.75 and the 200-day simple moving average is $3.31. Key support is at $1.23 and resistance at $1.81. The asset shows an annualized volatility of 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.23 | $1.25 | $1.51 | 0% | Neutral | |
| $0.5148 | $0.6862 | $0.9839 | -45% | Bearish | |
| $1.27 | $1.78 | $2.69 | +42% | Bullish | |
| $1.34 | $1.96 | $3.09 | +57% | Bullish | |
| $1.12 | $1.70 | $2.77 | +36% | Bullish | |
| $0.6566 | $1.02 | $1.73 | -18% | Bearish | |
| $0.831 | $1.34 | $2.32 | +7% | Neutral | |
| $1.63 | $2.71 | $4.80 | +117% | Bullish | |
| $1.21 | $2.07 | $3.76 | +66% | Bullish | |
| $0.6837 | $1.20 | $2.22 | -4% | Neutral | |
| $0.7358 | $1.48 | $2.97 | +18% | Neutral | |
| $2.24 | $4.98 | $11.28 | +298% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.23 | $1.25 | $1.67 | +0.00% |
| August 2026 | $1.10 | $1.32 | $1.66 | +5.90% |
| September 2026 | $0.9398 | $1.14 | $1.46 | -13.53% |
| October 2026 | $0.9931 | $1.22 | $1.57 | +6.67% |
| November 2026 | $1.08 | $1.34 | $1.75 | +9.82% |
| December 2026 | $0.9168 | $1.15 | $1.51 | -14.61% |
Click any year to see its month-by-month MLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Enzyme's 2026 outlook centres on $1.25, within a $1.23 to $1.51 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MLN could reach as high as $0.9839, with a base case around $0.6862 and support toward $0.5148 — roughly -45% from $1.25. Expect choppier, lower action through this leg of the cycle.
Expect MLN to range from $1.27 to $2.69 through 2028. The $1.78 average target implies a +42% move from current prices. That is up +159% on the projected 2027 average. Momentum favours further upside here.
The MLN price prediction for 2029 points to an average of $1.96 (low $1.34, high $3.09) — a potential gain of +57% on today's $1.25. Buyers look set to stay in control over this stretch.
In 2030, MLN is projected to trade between $1.12 and $2.77, averaging $1.70 — a potential gain of +36% from today's $1.25. That is -13% versus the projected 2029 average. Momentum favours further upside here.
Enzyme's 2031 outlook centres on $1.02, within a $0.6566 to $1.73 range. That is -40% versus the projected 2030 average. That marks a -18% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2032, MLN could reach as high as $2.32, with a base case around $1.34 and support toward $0.831 — roughly +7% from $1.25. Price action looks broadly range-bound.
Expect MLN to range from $1.63 to $4.80 through 2033. The $2.71 average target implies a +117% move from current prices. That is up +102% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MLN price prediction for 2034 points to an average of $2.07 (low $1.21, high $3.76) — a potential gain of +66% on today's $1.25. Momentum favours further upside here.
In 2035, MLN is projected to trade between $0.6837 and $2.22, averaging $1.20 — a potential decline of -4% from today's $1.25. That is -42% versus the projected 2034 average. A consolidation phase looks the most probable path here.
Enzyme's 2040 outlook centres on $1.48, within a $0.7358 to $2.97 range. That is up +23% on the projected 2035 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2050, MLN could reach as high as $11.28, with a base case around $4.98 and support toward $2.24 — roughly +298% from $1.25. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLN today (≈ 800 MLN) could be worth
$3,984.12
+$2,984.12 (+298%) by 2050 · US Dollar
Based on the average projected MLN price of $4.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLNwould be worth at today's price.
$1,000 invested in MLN on Jul 1, 2025 (≈ 140.513892 MLN) would be worth
$175.64
-$824.36 (-82.4%) today · 0.18× · US Dollar
Based on a MLN entry price of $7.12 vs. today's $1.25.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.35 | $922.83 | -7.7% |
| 1 month ago | $1.96 | $639.34 | -36.1% |
| 3 months ago | $3.18 | $393.19 | -60.7% |
| 6 months ago | $4.79 | $260.98 | -73.9% |
| 1 year ago | $7.12 | $175.64 | -82.4% |
| All time (1.1y) ago | $8.27 | $151.24 | -84.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLN forecast.
Our base-case forecast reaches $2.50 around 2033.
Implied market cap at $2.50: $8.19M
The multi-year forecast shows a pattern of bullish years and bearish years. Notable bullish years include 2028 (avg $1.78; ROI 42.4%), 2029 (avg $1.96; ROI 56.6%), 2033 (avg $2.71; ROI 116.5%), 2034 (avg $2.07; ROI 66%), and 2050 (avg $4.98; ROI 298.4%). Bearish years include 2027 (avg $0.6862; ROI -45.1%) and 2031 (avg $1.02; ROI -18%).
The forecast also marks 2030 (avg $1.70; ROI 35.6%) and 2040 (avg $1.48; ROI 18.2%), illustrating an overall upward drift with significant volatility. The 2050 maximum is $11.28, underscoring the upside potential, balanced by the risk of downside moves in certain years.
Tap a question to reveal the answer.
In 2030, the forecast shows a min of $1.12, an average of $1.70, a max of $2.77, with a 35.6% ROI and bullish sentiment.
The forecast includes a mix of bullish and bearish years. Notable bullish years include 2028 (avg $1.78, ROI 42.4%), 2029 (avg $1.96, ROI 56.6%), 2033 (avg $2.71, ROI 116.5%), 2034 (avg $2.07, ROI 66%), and 2050 (avg $4.98, ROI 298.4%). Bearish years include 2027 (avg $0.6862, ROI -45.1%) and 2031 (avg $1.02, ROI -18%).
The forecast maximum in 2050 is $11.28.
Current price is $1.25; market cap is $4.1M. It is ranked 1678.
The 30-day range is $0.9839 to $1.59.
Enzyme Community Discussion
0Share your Enzyme price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.